These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 13723506)

  • 1. The intranasal infection of mice with Bordetella pertussis.
    DOLBY JM; THOW DC; STANDFAST AF
    J Hyg (Lond); 1961 Jun; 59(2):191-204. PubMed ID: 13723506
    [No Abstract]   [Full Text] [Related]  

  • 2. The intracerebral infection of mice with Bordetella pertussis.
    DOLBY JM; STANDFAST AF
    J Hyg (Lond); 1961 Jun; 59(2):205-16. PubMed ID: 13723505
    [No Abstract]   [Full Text] [Related]  

  • 3. Development of vaccines against pertussis caused by Bordetella holmesii using a mouse intranasal challenge model.
    Saito M; Odanaka K; Otsuka N; Kamachi K; Watanabe M
    Microbiol Immunol; 2016 Sep; 60(9):599-608. PubMed ID: 27515393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protocol for aerosolization challenge of mice with Bordetella pertussis.
    Bitzer G; Weaver K; Barbier M; Damron FH
    STAR Protoc; 2023 Mar; 4(1):101979. PubMed ID: 36598856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The altered reactivity of mice after inoculation with Bordetella pertussis vaccine.
    KIND LS
    Bacteriol Rev; 1958 Sep; 22(3):173-82. PubMed ID: 13572280
    [No Abstract]   [Full Text] [Related]  

  • 6. Protective effects of vaccines against Bordetella parapertussis in a mouse intranasal challenge model.
    Komatsu E; Yamaguchi F; Eguchi M; Watanabe M
    Vaccine; 2010 Jun; 28(27):4362-8. PubMed ID: 20438876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Active immunity in mice following the intranasal injection of sublethal doses of living Haemophilus pertussis.
    COOPER GN
    J Pathol Bacteriol; 1952 Jan; 64(1):65-74. PubMed ID: 14908789
    [No Abstract]   [Full Text] [Related]  

  • 8. Relationship of increased histidine decarboxylase activity to Bordetella pertussis vaccine sensitization of mice.
    SCHAYER RW; GANLEY OH
    J Allergy; 1961; 32():204-13. PubMed ID: 13747330
    [No Abstract]   [Full Text] [Related]  

  • 9. The immunology of bordetella pertussis infection.
    Mills KH; Ryan M; Mcguirk P; Griffin F; Murphy G; Mahon B
    Biologicals; 1999 Jun; 27(2):77. PubMed ID: 10600187
    [No Abstract]   [Full Text] [Related]  

  • 10. Mice are protected against Bordetella pertussis infection by intra-nasal immunization with filamentous haemagglutinin.
    Cahill ES; O'Hagan DT; Illum L; Redhead K
    FEMS Microbiol Lett; 1993 Mar; 107(2-3):211-6. PubMed ID: 8472903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homologous and heterologous protection after single intranasal administration of live attenuated recombinant Bordetella pertussis.
    Mielcarek N; Riveau G; Remoué F; Antoine R; Capron A; Locht C
    Nat Biotechnol; 1998 May; 16(5):454-7. PubMed ID: 9592394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemagglutination test for pertussis antibody with a soluble extract of Bordetella pertussis.
    SCHUBERT JH; ELEFF MG; HERMANN GJ
    Am J Public Health Nations Health; 1961 Mar; 51(3):441-5. PubMed ID: 13748713
    [No Abstract]   [Full Text] [Related]  

  • 13. [Experimental whooping cough of nonhuman primate].
    Kubrava DT; Medkova AIu; Siniashina LN; Shevtsova ZV; Matua AZ; Kondzharia IG; Barkaia VS; Elistratova ZhV; Karataev GI; Mikvabia ZIa; Gintsburg AL
    Vestn Ross Akad Med Nauk; 2013; (8):28-33. PubMed ID: 24340642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fluid cultures of Hemophilus pertussis. II. Comparative protective properties (in the mouse) of various fractions].
    FRAPPIER A; GUERAULT A
    Rev Can Biol; 1955 Dec; 14(3):193-208. PubMed ID: 13311014
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison between pertussis vaccine potency assays in mice challenged by the intracerebral route and mice challenged by the intranasal route (sublethal dose).
    ANDERSEN EK; BENTZON MW
    Acta Pathol Microbiol Scand; 1958; 42(4):333-56. PubMed ID: 13532706
    [No Abstract]   [Full Text] [Related]  

  • 16. [Aerosol inoculation of Bordetella pertussis in mice].
    Sato Y; Arai H
    Nihon Saikingaku Zasshi; 1975 Jan; 30(1):198. PubMed ID: 175185
    [No Abstract]   [Full Text] [Related]  

  • 17. Live attenuated B. pertussis as a single-dose nasal vaccine against whooping cough.
    Mielcarek N; Debrie AS; Raze D; Bertout J; Rouanet C; Younes AB; Creusy C; Engle J; Goldman WE; Locht C
    PLoS Pathog; 2006 Jul; 2(7):e65. PubMed ID: 16839199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cellular immune response to Bordetella pertussis in two children with whooping cough.
    Hafler JP; Pohl-Koppe A
    Eur J Med Res; 1998 Nov; 3(11):523-6. PubMed ID: 9810032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The O antigen enables Bordetella parapertussis to avoid Bordetella pertussis-induced immunity.
    Wolfe DN; Goebel EM; Bjornstad ON; Restif O; Harvill ET
    Infect Immun; 2007 Oct; 75(10):4972-9. PubMed ID: 17698566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Method of preparation of whooping cough vaccines. I. Effect of increased aeration on dynamics of multiplication of Hemophilus pertussis in fluid medium].
    ANATOLII SA
    Zh Mikrobiol Epidemiol Immunobiol; 1955 Nov; (11):77-83. PubMed ID: 13300901
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.